Axentis Pharma has received orphan drug designation (ODD) in the US for its cystic fibrosis treatment, which uses liposomes to deliver prolonged high-concentrations of a therapeutic to the infected area.
Californian pharmaceutical firm Aradigm has unveiled positive
safety and efficacy data from an open-label study of its once daily
inhaled liposomal antibiotic ciprofloxacin in patients with cystic
The search for novel drug targets for cystic fibrosis received a
boost after Dutch biotechnology company Galapagos announced the
extension of its alliance with Cystic Fibrosis Foundation
Therapeutics (CFFT), the non-profit drug discovery...
Scientists have discovered an unusual distribution of two proteins
in the lungs and airways of people with cystic fibrosis could form
the basis of a therapy that could better define the immune system's
role in cystic fibrosis.
Vertex Pharmaceutcals was one of a number of pharma and biotech
companies to attend the PiperJaffray healthcare conference in
London last week, which gave international companies the
opportunity to provide pipeline updates.
Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation
Therapeutics, (CFFT) have announced they have entered into a
collaboration to develop a novel, oral drug candidate for the
treatment of cystic fibrosis (CF).
Vertex Pharmaceuticals and Cystic Fibrosis Foundation Therapeutics
have extended their research collaboration initiated in May 2000,
in which CFFT will provide an additional $22 million to further
develop Vertex's therapies that...
Forest Laboratories, having developed what it believes is the
world's first dry powder inhalation system for antibiotics, is now
conducting phase III trials on a new dry powder antibiotic
formulation which promises to change...
US researchers believe they have discovered a new method in
designing a better drug to treat cystic fibrosis - a disease that
currently has no cure. The scientists eventually hope a drug can be
produced that would work efficiently...
An electronic nebuliser that matches a product formulation, which
was specifically developed to optimise this device's performance,
marks a new advance in the customisation of drug development and
represents a new aerosol delivery...
Structural GenomiX (SGX) and the Cystic Fibrosis Foundation, have
made a breakthrough in Cystic Fibrosis (CF) research by identifying
the three-dimensional crystal structure of a protein that has been
implicated in the onset of the...
Profile Therapeutics of the UK, a specialist in inhaled therapies,
said it has agreed to supply France's Schering SA with its Prodose
intelligent inhalers to support Schering's product Ventavis
(iloprost), a recently-approved...